Literature DB >> 25786867

Delivery of proteins to CNS as seen and measured by positron emission tomography.

Mikhail I Papisov1, V Belov, A J Fischman, E Belova, J Titus, M Gagne, C Gillooly.   

Abstract

Presently, there are no effective treatments for several diseases involving the central nervous system (CNS). While several novel molecular approaches are being developed, many of them require delivery of macromolecular or supramolecular agents to the CNS tissues protected by the blood-brain and blood-arachnoid barriers. A variety of approaches that are being developed for overcoming or bypassing the barriers are based on complex transfer processes. The delivery of biopharmaceuticals and other macromolecules and particulates to the CNS, especially through the leptomeningeal (intrathecal) route, includes a variety of stages, such as leptomeningeal propagation, drainage to the systemic circulation, and penetration into the CNS. The investigation of complex pharmacokinetics that includes convective, as well as diffusional and active transfer processes, greatly benefit from real-time non-invasive in vivo monitoring of the drug transport. Pharmacological positron emission tomography (PET) imaging, which enables such monitoring, plays an increasingly significant role in drug delivery and biopharmacology. PET is a powerful tool for quantitative in vivo tracking of molecules labeled with positron-emitting radionuclides. The high sensitivity, format, and accuracy of the data (similar to those of conventional tissue sampling biodistribution studies) make PET a readily adoptable pharmacological technique. In contrast to the conventional studies, PET also allows for longitudinal nonterminal same-animal studies. The latter may not only improve the data statistics, but also enable preclinical studies (especially in large and/or rare animals) not feasible under the conventional approach. This paper is intended to demonstrate the character of data that can be obtained by PET and to demonstrate how the main patterns of the leptomeningeal route pharmacokinetics can be investigated using this method. Examples of data processing are taken from our recent studies of five model proteins in rats and nonhuman primates.

Entities:  

Year:  2012        PMID: 25786867      PMCID: PMC4417608          DOI: 10.1007/s13346-012-0073-3

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  10 in total

1.  Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream.

Authors:  Marco A Passini; Edward B Lee; Gregory G Heuer; John H Wolfe
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

2.  DISTRIBUTION OF RADIO-IODINE STUDIED BY WHOLE-BODY AUTORADIOGRAPHY.

Authors:  S ULLBERG; B EWALDSSON
Journal:  Acta Radiol Ther Phys Biol       Date:  1964-02

3.  INFLUENCE OF THE GASTROINTESTINAL IODIDE CYCLE ON THE EARLY DISTRIBUTION OF RADIOACTIVE IODIDE IN MAN.

Authors:  M T HAYS; D H SOLOMON
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

4.  Subarachnoid distribution of drugs after lumbar injection.

Authors:  R E RIESELBACH; G DI CHIRO; E J FREIREICH; D P RALL
Journal:  N Engl J Med       Date:  1962-12-20       Impact factor: 91.245

5.  Exact and approximate rebinning algorithms for 3-D PET data.

Authors:  M Defrise; P E Kinahan; D W Townsend; C Michel; M Sibomana; D F Newport
Journal:  IEEE Trans Med Imaging       Date:  1997-04       Impact factor: 10.048

6.  Spinal descent of cerebrospinal fluid in man.

Authors:  G D Chiro; M K Hammock; W A Bleyer
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

7.  Iodine-124 as a label for pharmacological PET imaging.

Authors:  Vasily V Belov; Ali A Bonab; Alan J Fischman; Michael Heartlein; Pericles Calias; Mikhail I Papisov
Journal:  Mol Pharm       Date:  2011-04-06       Impact factor: 4.939

8.  Iodotyrosine deiodinase is the first mammalian member of the NADH oxidase/flavin reductase superfamily.

Authors:  Jessica E Friedman; James A Watson; David W-H Lam; Steven E Rokita
Journal:  J Biol Chem       Date:  2005-11-29       Impact factor: 5.157

9.  Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space.

Authors:  M L Rennels; T F Gregory; O R Blaumanis; K Fujimoto; P A Grady
Journal:  Brain Res       Date:  1985-02-04       Impact factor: 3.252

10.  CNS penetration of intrathecal-lumbar idursulfase in the monkey, dog and mouse: implications for neurological outcomes of lysosomal storage disorder.

Authors:  Pericles Calias; Mikhail Papisov; Jing Pan; Nancy Savioli; Vasily Belov; Yan Huang; Jason Lotterhand; Mary Alessandrini; Nan Liu; Alan J Fischman; Jan L Powell; Michael W Heartlein
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

  10 in total
  13 in total

Review 1.  Physiology of the intrathecal bolus: the leptomeningeal route for macromolecule and particle delivery to CNS.

Authors:  Mikhail I Papisov; Vasily V Belov; Kimberley S Gannon
Journal:  Mol Pharm       Date:  2013-02-12       Impact factor: 4.939

Review 2.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

3.  Investigation of intrathecal transport of NPT002, a prospective therapeutic based on phage M13, in nonhuman primates.

Authors:  Mikhail I Papisov; V Belov; E Belova; A J Fischman; R Fisher; J L Wright; K S Gannon; J Titus; M Gagne; C A Gillooly
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

4.  Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging.

Authors:  Curt Mazur; Berit Powers; Kenneth Zasadny; Jenna M Sullivan; Hemi Dimant; Fredrik Kamme; Jacob Hesterman; John Matson; Michael Oestergaard; Marc Seaman; Robert W Holt; Mohammed Qutaish; Ildiko Polyak; Richard Coelho; Vijay Gottumukkala; Carolynn M Gaut; Marc Berridge; Nazira J Albargothy; Louise Kelly; Roxana O Carare; Jack Hoppin; Holly Kordasiewicz; Eric E Swayze; Ajay Verma
Journal:  JCI Insight       Date:  2019-10-17

5.  Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates.

Authors:  Douglas J Ballon; Jonathan B Rosenberg; Edward K Fung; Anastasia Nikolopoulou; Paresh Kothari; Bishnu P De; Bin He; Alvin Chen; Linda A Heier; Dolan Sondhi; Stephen M Kaminsky; Paul David Mozley; John W Babich; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2020-12       Impact factor: 5.695

6.  Biodistribution of Adeno-Associated Virus Serotype 5 Viral Vectors Following Intrathecal Injection.

Authors:  Kelsey R Pflepsen; Cristina D Peterson; Kelley F Kitto; Maureen S Riedl; R Scott McIvor; George L Wilcox; Lucy Vulchanova; Carolyn A Fairbanks
Journal:  Mol Pharm       Date:  2021-08-30       Impact factor: 5.364

Review 7.  Intrathecal drug delivery in the era of nanomedicine.

Authors:  M J Fowler; J D Cotter; B E Knight; E M Sevick-Muraca; D I Sandberg; R W Sirianni
Journal:  Adv Drug Deliv Rev       Date:  2020-03-03       Impact factor: 15.470

8.  The Configuration of the Perivascular System Transporting Macromolecules in the CNS.

Authors:  Beata Durcanova; Janine Appleton; Nyshidha Gurijala; Vasily Belov; Pilar Giffenig; Elisabeth Moeller; Matthew Hogan; Fredella Lee; Mikhail Papisov
Journal:  Front Neurosci       Date:  2019-05-28       Impact factor: 4.677

9.  Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice.

Authors:  K T Householder; S Dharmaraj; D I Sandberg; R J Wechsler-Reya; R W Sirianni
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

10.  Radioiodination of aryl-alkyl cyclic sulfates.

Authors:  Chandra Mushti; Mikhail I Papisov I Papisov
Journal:  Molecules       Date:  2012-11-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.